The University of Cambridge is launching a new Institute aimed at tackling one of the biggest bottlenecks in UK medical research: turning promising laboratory discoveries into regulated devices that can be tested with patients.
Cambridge researchers are developing implants that could help repair the brain pathways damaged by Parkinson’s disease.
A team from across the Cambridge life sciences, technology and business worlds has announced a multi-million-pound, three-year collaboration with the Advanced Research and Invention Agency (ARIA), the UK government’s new research funding agency.
Researchers have developed soft, stretchable ‘jelly batteries’ that could be used for wearable devices or soft robotics, or even implanted in the brain to deliver drugs or treat conditions such as epilepsy.
Ten outstanding Cambridge researchers have been elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.
A tiny, flexible electronic device that wraps around the spinal cord could represent a new approach to the treatment of spinal injuries, which can cause profound disability and paralysis.
Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them.
Researchers have developed a new type of neural implant that could restore limb function to amputees and others who have lost the use of their arms or legs.
Researchers in Cambridge’s Bioelectronics Lab are developing implantable devices to bypass nerve damage and restore movement to paralysed limbs.
Cambridge leads a £10 million interdisciplinary collaboration to target the most challenging of cancers.
© 2026 University of Cambridge